Entering the New Year with Confidence

The beginning of the year is the moment when perspective turns into concrete action. We use this opportunity to sharpen our focus on the priorities that will guide our work in the year ahead.

We start the new year with confidence. Our focus is on advancing our breakthrough innovation further into clinical practice and enabling measurably better outcomes in the treatment of chronic, acute, and infected wounds.

Our Argon Jet Plasma Technology combines high technical accuracy with therapeutic effectiveness. It is designed to support more stable healing processes, reduce complications, and deliver tangible improvements in the daily clinical routine for patients and healthcare professionals.

Especially in a healthcare system under significant pressure, innovation must prove itself in real-world care settings and demonstrate sustainable, evidence-based impact.

We do not take this path alone. We would like to thank the entire Neoplas team, as well as our partners, users, and investors, for their trust and the strong collaboration.

In 2026, we will continue on this path with the same consistency and a strong spirit of collaboration: strengthening our technology leadership through clinical evidence and expanding our technology into additional medical applications – so that patients worldwide can benefit.